- Home
- VRAR vs NMTC Comparison
VRAR vs NMTC Comparison
Compare VRAR & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAR
- NMTC
- Stock Information
- Founded
- VRAR 2016
- NMTC 2009
- Country
- VRAR United States
- NMTC United States
- Employees
- VRAR N/A
- NMTC N/A
- Industry
- VRAR Retail: Computer Software & Peripheral Equipment
- NMTC Medical/Dental Instruments
- Sector
- VRAR Technology
- NMTC Health Care
- Exchange
- VRAR Nasdaq
- NMTC Nasdaq
- Market Cap
- VRAR 33.3M
- NMTC 33.8M
- IPO Year
- VRAR 2021
- NMTC N/A
- Fundamental
- Price
- VRAR $1.45
- NMTC $0.75
- Analyst Decision
- VRAR Strong Buy
- NMTC Strong Buy
- Analyst Count
- VRAR 1
- NMTC 1
- Target Price
- VRAR $2.62
- NMTC $1.45
- AVG Volume (30 Days)
- VRAR 125.3K
- NMTC 180.3K
- Earning Date
- VRAR 05-15-2025
- NMTC 08-13-2025
- Dividend Yield
- VRAR N/A
- NMTC N/A
- EPS Growth
- VRAR N/A
- NMTC N/A
- EPS
- VRAR N/A
- NMTC N/A
- Revenue
- VRAR $8,756,789.00
- NMTC $5,758,777.00
- Revenue This Year
- VRAR $6.59
- NMTC $141.04
- Revenue Next Year
- VRAR $30.43
- NMTC $38.86
- P/E Ratio
- VRAR N/A
- NMTC N/A
- Revenue Growth
- VRAR N/A
- NMTC 54.53
- 52 Week Low
- VRAR $0.50
- NMTC $0.40
- 52 Week High
- VRAR $7.00
- NMTC $1.39
- Technical
- Relative Strength Index (RSI)
- VRAR 54.34
- NMTC 65.91
- Support Level
- VRAR $1.40
- NMTC $0.72
- Resistance Level
- VRAR $1.38
- NMTC $0.77
- Average True Range (ATR)
- VRAR 0.10
- NMTC 0.05
- MACD
- VRAR 0.01
- NMTC 0.01
- Stochastic Oscillator
- VRAR 72.00
- NMTC 85.88
About VRAR The Glimpse Group Inc.
The Glimpse Group Inc is a diversified Virtual and Augmented Reality platform company, comprised of multiple VR and AR software and services companies, and designed with the specific purpose of cultivating companies in the emerging VR/AR industry.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.